Additionally, no synergistic effect of the inhibition of NF-κB and MYC signaling was detectable in NSCLC-derived LCSC-like cells, suggesting either inhibition of MYC signaling or NF-κB signaling to inhibit survival of LCSCs without a cross-coupling between the two pathways. The gene discussed is MYC; the disease is non-small cell lung carcinoma.